Versant Venture Management »

Contineum Therapeutics shares owned by Versant Venture Management

Quarter-by-quarter ownership of Contineum Therapeutics shares owned by Versant Venture Management from 13F filings

Historical chart of Versant Venture Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Versant Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Versant Venture Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $16M 918k 17.61

More positions owned by Versant Venture Management

CRISPR Therapeutics Common Shares (CRSP)
Contineum Therapeutics Common Stock
Skye Bioscience Common Stock (SKYE)
Repare Therapeutics Common Stock (RPTX)
Adverum Biotechnologies Common Stock
Passage Bio Common Stock (PASG)
Gritstone Oncology Common Stock (GRTS)
Aligos Therapeutics Common Stock (ALGS)

View all positions for Versant Venture Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Johnson & Johnson
Perceptive Advisors
Versant Venture Management
Hillhouse Capital Advisors
Franklin Resources
Samsara BioCapital
Vanguard Group
Altium Capital Management
BlackRock
Baker Bros. Advisors
Casdin Capital
Geode Capital Management
Squarepoint Ops
Citadel Advisors

View all funds holding Contineum Therapeutics